Home  >  Products  >  MAP3K14 (mitogen-activated protein kinase kinase kinase 14) Blocking Peptide (the N terminal of MAP3K14)(100ug)
MAP3K14 (mitogen-activated protein kinase kinase kinase 14) Blocking Peptide (the N terminal of MAP3K14)(100ug)

MAP3K14 (mitogen-activated protein kinase kinase kinase 14) Blocking Peptide (the N terminal of MAP3K14)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MAP3K14 Antibody(ARP42161_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP42161
Size: 100ug
Weight: 104kDa
Gene: 9020
Format: Lyophilized powder
Target: This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor.
Alternative names: FTDCR1B; HS; HSNIK; NIK
See Full Product Listings >